Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an Adenovirus based melanoma vaccine

Adenovirus (Ad)-based vaccines are considered for cancer immunotherapy, yet, detailed knowledge on their mechanism of action and optimal delivery route for anti-tumor efficacy is lacking. Here, we compared the anti-tumor efficacy of an Ad-based melanoma vaccine after intradermal, intravenous, intran...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hangalapura, Basav N, Oosterhoff, Dinja, Gupta, Tarun, de Groot, Jan, Wijnands, Pepijn GJTB, van Beusechem, Victor W., den Haan, Joke, Tüting, Thomas, van den Eertwegh, Alfons JM, Curiel, David T, Scheper, Rik J, de Gruijl, Tanja D
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3058128/
https://ncbi.nlm.nih.gov/pubmed/21272606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2011.01.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados